The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
Pete Giacchi, Citadel Securities, joins 'Money Movers' to discuss Venture Global's initial public offering, the biggest IPO ...
2024 saw a significant rebound in the IPO market relative to 2023, with nearly 50% more IPOs in 2024 than in the year prior ...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...
After what many considered a “slow” year for IPOs, January has ushered in a string of biotechs filing to go public. But 2024 ...
The IPO consists of fresh issue of shares worth up to 15 billion rupees, while existing shareholder Menon Family Holdings ...
When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...
The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...
U.S. liquefied natural gas exporter Venture Global couldn’t have timed its initial public offering better: It comes just days ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback